Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Tirzepatide (as Mounjaro or Zepbound) is approved for type 2 diabetes and/or weight management in the following countries: Additionally, in December 2024, the United States FDA revised the indication for tirzepatide (branded as Zepbound) to include the treatment of moderate to severe obstructive sleep apnea
Individual tolerability varies based on genetics, body composition, and concurrent medications
A provider must determine whether Tirzepatide is clinically appropriate based on medical history, goals, and safety factors
Weekly cycling: 5 on, 2 off The most common approach for GH secretagogues
Others may maintain baseline appetite better, allowing standard protein targets to feel natural
These salt forms have different chemical structures and have not been shown to be safe or effective in humans
US$ 21.58
US$ 27.05
US$ 27.01
US$ 26.69
US$ 27.74
